Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection

Overview

Journal J Prim Care Community Health

Publisher Sage Publications

Specialty Health Services

Date 2024 Oct 29

PMID 39471195

Authors

Adam F Aldhawyan

Mohammed A BuSaad

Bothayna A Alamri

Mohammed I Alsaihati

Bader S Alanazi

Rawan A Alanazi

Ahmed S Bahamdan

Affiliations

Soon will be listed here.

Abstract

Introduction/objective: As the coronavirus disease 2019 (COVID-19) pandemic progressed, the virus was found to cause long-term health complications known as long COVID (LC). This study aimed to investigate LC symptom severity and the factors associated with the likelihood of persistence beyond 1 year among COVID-19 survivors in Saudi Arabia.

Methods: This descriptive, cross-sectional, questionnaire-based study was conducted via convenience sampling between December 1, 2023, and March 1, 2024. In-person interviews were performed, and 845 individuals with persistent symptoms after acute COVID-19 were included.

Results: Hair loss and memory impairment were the most reported symptoms. In predicting LC persistence beyond 12 months, women were found to have higher odds of being symptomatic than men, and individuals from moderate-to-high-income households were more likely to report persistent symptoms than those from low-income households. Each additional acute COVID-19 symptom increased the likelihood of persistent symptoms by 1.14 times. Reporting more symptoms in the first 6 months post-infection significantly reduced the odds of long-term symptoms by approximately 30%.

Conclusion: LC symptom severity varies among patients, and sociodemographic and clinical factors influence the likelihood of experiencing symptoms beyond 1 year. Understanding these factors can provide insights and help optimize management, leading to improved patient outcomes.

References

Luo M, Guo L, Yu M, Jiang W, Wang H . The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - A systematic review and meta-analysis. Psychiatry Res. 2020; 291:113190. PMC: 7276119. DOI: 10.1016/j.psychres.2020.113190. View

Peiris S, Mesa H, Aysola A, Manivel J, Toledo J, Borges-Sa M . Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS One. 2021; 16(4):e0250708. PMC: 8081217. DOI: 10.1371/journal.pone.0250708. View

Liu J, Li Y, Liu L, Hu X, Wang X, Hu H . Infection of human sweat glands by SARS-CoV-2. Cell Discov. 2020; 6(1):84. PMC: 7661176. DOI: 10.1038/s41421-020-00229-y. View

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Surapaneni K, Singhal M, Saggu S, Bhatt A, Shunmathy P, Joshi A . A Scoping Review on Long COVID-19: Physiological and Psychological Symptoms Post-Acute, Long-Post and Persistent Post COVID-19. Healthcare (Basel). 2022; 10(12). PMC: 9778115. DOI: 10.3390/healthcare10122418. View

Johnston C, Hughes H, Lingard S, Hailey S, Healy B . Immunity and infectivity in covid-19. BMJ. 2022; 378:e061402. DOI: 10.1136/bmj-2020-061402. View

Durstenfeld M, Peluso M, Peyser N, Lin F, Knight S, Djibo A . Factors Associated With Long COVID Symptoms in an Online Cohort Study. Open Forum Infect Dis. 2023; 10(2):ofad047. PMC: 9945931. DOI: 10.1093/ofid/ofad047. View

Rodrigues A, Dias A, Paranhos A, Silva C, Bastos T, de Brito B . Headache in long COVID as disabling condition: A clinical approach. Front Neurol. 2023; 14:1149294. PMC: 10076861. DOI: 10.3389/fneur.2023.1149294. View

Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021; 27(10):1507-1513. PMC: 8180450. DOI: 10.1016/j.cmi.2021.05.033. View

10.

Nouraeinejad A . Memory loss in patients with long COVID can be due to reduced hippocampal neurogenesis. Eur Arch Psychiatry Clin Neurosci. 2023; 275(1):267-268. PMC: 10111313. DOI: 10.1007/s00406-023-01610-0. View

11.

Premraj L, Kannapadi N, Briggs J, Seal S, Battaglini D, Fanning J . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022; 434:120162. PMC: 8798975. DOI: 10.1016/j.jns.2022.120162. View

12.

Krishna B, Wills M, Sithole N . Long COVID: what is known and what gaps need to be addressed. Br Med Bull. 2023; 147(1):6-19. PMC: 10502447. DOI: 10.1093/bmb/ldad016. View

13.

Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R . Long covid-an update for primary care. BMJ. 2022; 378:e072117. DOI: 10.1136/bmj-2022-072117. View

14.

Mahmoud N, Radwan N, Alkattan A, Hassanien M, Elkajam E, AlQahtani S . Post-COVID-19 syndrome: nature of symptoms and associated factors. Z Gesundh Wiss. 2023; :1-6. PMC: 9809515. DOI: 10.1007/s10389-022-01802-3. View

15.

Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

16.

Khodeir M, Shabana H, Rasheed Z, Alkhamiss A, Khodeir M, Alkhowailed M . COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia. PLoS One. 2021; 16(12):e0260259. PMC: 8654233. DOI: 10.1371/journal.pone.0260259. View

17.

Iadecola C, Anrather J, Kamel H . Effects of COVID-19 on the Nervous System. Cell. 2020; 183(1):16-27.e1. PMC: 7437501. DOI: 10.1016/j.cell.2020.08.028. View

18.

Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022; 54(1):1473-1487. PMC: 9132392. DOI: 10.1080/07853890.2022.2076901. View

19.

Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022; 13(1):1957. PMC: 9005552. DOI: 10.1038/s41467-022-29521-z. View

20.

Proal A, VanElzakker M . Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021; 12:698169. PMC: 8260991. DOI: 10.3389/fmicb.2021.698169. View